Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FGFR1 | P11362 | 1/20 | 0.35 |
| ▸ | FGFR2 | P21802 | 1/20 | 0.35 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.35 |
| ▸ | FGFR3 | P22607 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27845971 | 0.90 | FGFR1 (0.38) | FGFR1FGFR2FGFR4FGFR3 | |
| SCHEMBL27841889 | 0.86 | FGFR1 (0.41) | FGFR1FGFR2FGFR4FGFR3 | |
| SCHEMBL1063742 | 0.86 | — | — | |
| SCHEMBL226836 | 0.83 | — | — | |
| SCHEMBL8846964 | 0.82 | — | — | |
| SCHEMBL11314685 | 0.81 | — | — | |
| SCHEMBL6291667 | 0.81 | — | — | |
| SCHEMBL28107586 | 0.79 | — | — | |
| SCHEMBL9059026 | 0.78 | — | — | |
| SCHEMBL9510590 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12461102-B2 | Pristine graphene based biosensor for biomarker detection and related core particles, materials compositions methods and systems | HAWKEYE BIO, LIMITED (IE) | 2025-11-04 | — | — | US | claimed |
| WO-2024010609-A1 | PRISTINE GRAPHENE BASED BIOSENSOR FOR BIOMARKER DETECTION AND RELATED CORE PARTICLES, MATERIALS COMPOSITIONS METHODS AND SYSTEMS | HAWKEYE BIO, LIMITED (IE) | 2024-01-11 | — | — | WO | claimed |
| EP-4271651-A1 | PRISTINE GRAPHENE BASED BIOSENSOR FOR BIOMARKER DETECTION AND RELATED CORE PARTICLES, MATERIALS COMPOSITIONS METHODS AND SYSTEMS | HAWKEYE BIO, LIMITED (IE) | 2023-11-08 | — | — | EP | claimed |
| WO-2022147171-A1 | PRISTINE GRAPHENE BASED BIOSENSOR FOR BIOMARKER DETECTION AND RELATED CORE PARTICLES, MATERIALS COMPOSITIONS METHODS AND SYSTEMS | HAWKEYE BIO, LIMITED (US) | 2022-07-07 | — | — | WO | claimed |
| WO-2016018798-A1 | NANOSENSORS FOR DETECTING ENZYMATIC ACTIVITY IN DAIRY PRODUCTION | KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2016-02-04 | — | — | WO | claimed |
| US-8969027-B2 | Protease assay | KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2015-03-03 | — | — | US | claimed |
| EP-2473620-A2 | MRI AND OPTICAL ASSAYS FOR PROTEASES | Kansas State University Research Foundation (US) | 2012-07-11 | — | — | EP | claimed |
| JP-2011517934-A | — | — | 2011-06-23 | — | — | JP | claimed |
| WO-2011028698-A2 | MRI AND OPTICAL ASSAYS FOR PROTEASES | KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2011-03-10 | — | — | WO | claimed |
| US-20110014125-A1 | PROTEASE ASSAY | KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2011-01-20 | — | — | US | claimed |
| EP-2260108-A2 | PROTEASE ASSAY | Kansas State University Research Foundation (US) | 2010-12-15 | — | — | EP | claimed |
| WO-2009111470-A2 | PROTEASE ASSAY | KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2009-09-11 | — | — | WO | claimed |
| US-12461102-B2 | Pristine graphene based biosensor for biomarker detection and related core particles, materials compositions methods and systems | HAWKEYE BIO, LIMITED (IE) | 2025-11-04 | — | — | US | disclosed |
| EP-4271651-B1 | PRISTINE GRAPHENE BASED BIOSENSOR FOR BIOMARKER DETECTION AND RELATED CORE PARTICLES, MATERIALS COMPOSITIONS METHODS AND SYSTEMS | HAWKEYE BIO LTD (IE) | 2024-10-23 | — | — | EP | disclosed |
| US-11965881-B2 | Nanosensors and methods for detection of biological markers | KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2024-04-23 | — | — | US | disclosed |
| US-20240125800-A1 | NANOSENSORS FOR RAPID IDENTIFICATION OF LUNG CONDITIONS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2024-04-18 | — | — | US | disclosed |
| WO-2009111470-A2 | PROTEASE ASSAY | KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2009-09-11 | — | — | WO | disclosed |
| CN-101516319-A | Dental compositions including organogelators, products, and methods | 3M INNOVATIVE PROPERTIES CO (US) | 2009-08-26 | — | — | CN | disclosed |
| EP-0070686-B1 | NON-RADIATIVE ENERGY TRANSFER IMMUNOCHEMICAL TECHNIQUE | AMOCO CORPORATION (US) | 1985-10-02 | — | — | EP | disclosed |
| EP-0070686-A2 | Non-radiative energy transfer immunochemical technique | AMOCO CORPORATION (US) | 1983-01-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110014125-A1 | PROTEASE ASSAY | PREP, TMPRSS15, PRSS3 | FGFR1 3133/4885FGFR2 3512/4885FGFR4 2613/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.